Cargando…

SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis

Background and study aims  Endoscopic retrograde cholangiopancreatography (ERCP) and/or extracorporeal shock wave lithotripsy are first-line therapies for draining an obstructed pancreatic duct (PD) in painful chronic calcifying pancreatitis (CCP). Pancreaticoscopy has shown promising success rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerges, Christian, Pullmann, David, Bahin, Farzan, Schneider, Markus, Siersema, Peter D., Neuhaus, Horst, van Geenen, Erwin-Jan M., Beyna, Torsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336461/
https://www.ncbi.nlm.nih.gov/pubmed/30705939
http://dx.doi.org/10.1055/a-0808-4499
_version_ 1783388059690074112
author Gerges, Christian
Pullmann, David
Bahin, Farzan
Schneider, Markus
Siersema, Peter D.
Neuhaus, Horst
van Geenen, Erwin-Jan M.
Beyna, Torsten
author_facet Gerges, Christian
Pullmann, David
Bahin, Farzan
Schneider, Markus
Siersema, Peter D.
Neuhaus, Horst
van Geenen, Erwin-Jan M.
Beyna, Torsten
author_sort Gerges, Christian
collection PubMed
description Background and study aims  Endoscopic retrograde cholangiopancreatography (ERCP) and/or extracorporeal shock wave lithotripsy are first-line therapies for draining an obstructed pancreatic duct (PD) in painful chronic calcifying pancreatitis (CCP). Pancreaticoscopy has shown promising success rates in small series. Materials and methods  This study was a retrospective analysis of a clinical database. Included were all digital single-operator digital video (SOV) pancreaticoscopy-guided interventions (n = 23) on CCP patients (n = 20) between 2015 and 2017. Success and complication rates were collected from the database. Clinical success was determined by assessing pain level score (NRS) and quality of life (QoL) using standardized questionnaires. Results  Overall technical success rate (successful SOV-pancreaticoscopy and PD drainage) was 95 %. Adverse events occurred in 7 of 23 procedures (30 %) and included extravasation from the PD (n = 1), self-limiting post-sphincterotomy bleeding (n = 1) and post-ERCP pancreatitis (PEP) (n = 6). At 3- to 6-month follow-up, 95 % of patients reported improvement in symptoms and reduction in intake of analgesics. Mean NRS decreased from 5.4 (±1.6) to 2.8 (± 1.8) ( P  < 0.01). Clinical success was achieved in 95 % of patients. Conclusions  Digital SOV-guided lithotripsy was found to be safe and effective in this highly selected population of CCP patients. PD decompression had a beneficial effect on pain reduction and QoL.
format Online
Article
Text
id pubmed-6336461
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher © Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-63364612019-02-01 SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis Gerges, Christian Pullmann, David Bahin, Farzan Schneider, Markus Siersema, Peter D. Neuhaus, Horst van Geenen, Erwin-Jan M. Beyna, Torsten Endosc Int Open Background and study aims  Endoscopic retrograde cholangiopancreatography (ERCP) and/or extracorporeal shock wave lithotripsy are first-line therapies for draining an obstructed pancreatic duct (PD) in painful chronic calcifying pancreatitis (CCP). Pancreaticoscopy has shown promising success rates in small series. Materials and methods  This study was a retrospective analysis of a clinical database. Included were all digital single-operator digital video (SOV) pancreaticoscopy-guided interventions (n = 23) on CCP patients (n = 20) between 2015 and 2017. Success and complication rates were collected from the database. Clinical success was determined by assessing pain level score (NRS) and quality of life (QoL) using standardized questionnaires. Results  Overall technical success rate (successful SOV-pancreaticoscopy and PD drainage) was 95 %. Adverse events occurred in 7 of 23 procedures (30 %) and included extravasation from the PD (n = 1), self-limiting post-sphincterotomy bleeding (n = 1) and post-ERCP pancreatitis (PEP) (n = 6). At 3- to 6-month follow-up, 95 % of patients reported improvement in symptoms and reduction in intake of analgesics. Mean NRS decreased from 5.4 (±1.6) to 2.8 (± 1.8) ( P  < 0.01). Clinical success was achieved in 95 % of patients. Conclusions  Digital SOV-guided lithotripsy was found to be safe and effective in this highly selected population of CCP patients. PD decompression had a beneficial effect on pain reduction and QoL. © Georg Thieme Verlag KG 2019-02 2019-01-17 /pmc/articles/PMC6336461/ /pubmed/30705939 http://dx.doi.org/10.1055/a-0808-4499 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Gerges, Christian
Pullmann, David
Bahin, Farzan
Schneider, Markus
Siersema, Peter D.
Neuhaus, Horst
van Geenen, Erwin-Jan M.
Beyna, Torsten
SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis
title SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis
title_full SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis
title_fullStr SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis
title_full_unstemmed SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis
title_short SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis
title_sort spyglass ds-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336461/
https://www.ncbi.nlm.nih.gov/pubmed/30705939
http://dx.doi.org/10.1055/a-0808-4499
work_keys_str_mv AT gergeschristian spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis
AT pullmanndavid spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis
AT bahinfarzan spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis
AT schneidermarkus spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis
AT siersemapeterd spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis
AT neuhaushorst spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis
AT vangeenenerwinjanm spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis
AT beynatorsten spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis